Importantly, increased GLS1 expression has been documented in multiple malignancies, such as colorectal, breast, liver, lung, prostate and intrahepatic cholangiocarcinoma, where GLS1 upregulation correlates with enhanced Gln uptake, tumor progression and poor prognosis [80]. The gene discussed is GLS; the disease is intrahepatic cholangiocarcinoma.